PharmaCyte Biotech Inc (PMCB)

[PINKribbon]

I like the fact that the Practical Clinical staff being a former VP, and two Director’s, all from Abraxis/Celgene, would have had prior dealings with many CRO’s in their past at one level or another.

With both Sher and PC now knowing the experience and capacity needed in a CRO, I believe the pick will be a successful one.

But of course, with that comes the inevitable cost factor. A cost that we all know KW, as always, will manage to pay for.

Regardless of who it is or how much they cost, I still think we will see a new CRO PR before the end of the year. :) :) :)